← Back to all trials
Not Yet Recruiting
NCT05624242
Assessment of Right Ventricular Function by Cardiac MRI in Patients With Pulmonary Arterial Hypertension (IRMA)
Conditions: Pulmonary Arterial Hypertension
Sex: All
Ages: 18 Years – N/A
Enrollment: 130
Sponsor: Central Hospital, Nancy, France
Summary
Pulmonary hypertension (PH) is a pathophysiological condition defined by an increase in pulmonary arterial pressure above 20mmHg, which encompasses many very dissimilar conditions.
Right ventricular function is the major determinant of survival in these patients.
Currently, right ventricular function is estimated by trans-thoracic echocardiography via the measurement of standardised parameters.
However, cardiac magnetic resonance imaging is now the reference technique for non-invasive quantification of volumes, mass, function of the right ventricle but can also be useful for the consideration of the pulmonary circulation.
Thus, indices of function can be extracted and it plays an increasing role in the prognostic evaluation of the right heart function at diagnosis and at re-evaluation under treatment of pulmonary arterial hypertension.
This work will initially focus on the assessment of right ventricular myocardial work by echocardiography and cardiac magnetic resonance imaging in comparison with invasive haemodynamic data.
Eligibility Criteria
Inclusion Criteria:Patient with pulmonary arterial hypertension (group 1)Patient with cardiac MRI, echocardiography and right heart catheterisation within 1 month of each otherExclusion Criteria:Patient with features of venous/capillary involvementPulmonary arterial hypertension associated with with congenital heart diseasePatient's decline to participate in the study
Source: ClinicalTrials.gov (NCT05624242). StuddyBuddy aggregates publicly available trial information.